Form 8-K - Current report:
SEC Accession No. 0001213900-25-055402
Filing Date
2025-06-18
Accepted
2025-06-18 07:13:55
Documents
16
Period of Report
2025-06-18
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246139-8k_rafael.htm   iXBRL 8-K 34018
2 PRESS RELEASE, DATED JUNE 18, 2025. ea024613901ex99-1_rafael.htm EX-99.1 17984
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9123
4 GRAPHIC ex99-1_002.jpg GRAPHIC 13390
  Complete submission text file 0001213900-25-055402.txt   298170

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE rfl-20250618.xsd EX-101.SCH 3779
6 XBRL DEFINITION FILE rfl-20250618_def.xml EX-101.DEF 26620
7 XBRL LABEL FILE rfl-20250618_lab.xml EX-101.LAB 36675
8 XBRL PRESENTATION FILE rfl-20250618_pre.xml EX-101.PRE 25244
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0246139-8k_rafael_htm.xml XML 5559
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 251055124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)